Diabetes Management · 2013 · 25 citations · 125 references
Life SciencesImmunologyPathobiologyAutoimmunityCellular ImmunologyImmunotherapyAntigen RecognitionAutoantigensAutoimmune DiseasesDiabetes MellitusImmune ToleranceImmune Tolerance InductionAnimal Disease ModelsNaive T CellsPancreatic Islet CellsT-cell Epitope SpreadingT-cell Mediated ImmunityTolerance-inducing TherapiesType 1 Diabetes ModelsType 1 Diabetes Pathophysiology
Tolerogenic strategies that specifically target diabetogenic immune cells in the absence of complications of immunosuppression are the desired treatment for the prevention or even reversal of Type 1 diabetes (T1D). Antigen (Ag)-based therapies must not only suppress disease-initiating diabetogenic T cells that are already activated, but, more importantly, prevent activation of naive auto-Ag-specific T cells that may become autoreactive through epitope spreading as a result of Ag liberation from damaged islet cells. Therefore, identification of auto-Ags relevant to T1D initiation and progression is critical to the design of effective Ag-specific therapies. Animal models of T1D have been successfully employed to identify potential diabetogenic Ags, and have further facilitated translation of Ag-specific tolerance strategies into human clinical trials. In this review, we highlight important advances using animal models in Ag-specific T1D immunotherapies, and the application of the preclinical findings to human subjects. We provide an up-to-date overview of the strengths and weaknesses of various tolerance-inducing strategies, including infusion of soluble Ags/peptides by various routes of delivery, genetic vaccinations, cell- and inert particle-based tolerogenic approaches, and various other strategies that target distinct tolerance-inducing pathways.
125
Laura C. Bonifaz, David Bonnyay, Karsten Mahnke et al. · The Journal of Experimental Medicine · 2002 · 1.3K citations · Full text
Inducing and expanding regulatory T cell populations by foreign antigen
Karsten Kretschmer, Irina Apostolou, Daniel Hawiger et al. · Nature Immunology · 2005 · 1.2K citations
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment
Jerry P. Palmer, Christopher M. Asplin, Peter Clemons et al. · Science · 1983 · 1.1K citations
Medicine, Endocrinology, Immunology +15